Clinical Trials
2
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)NP2 Enkephalin For Treatment of Intractable Cancer Pain
Phase 2
Completed
- Conditions
- Intractable PainNeoplasms
- First Posted Date
- 2011-02-09
- Last Posted Date
- 2014-08-08
- Lead Sponsor
- Diamyd Inc
- Target Recruit Count
- 33
- Registration Number
- NCT01291901
- Locations
- 🇺🇸
HOPE Research Institute, Phoenix, Arizona, United States
🇺🇸Arizona Clinical Research Center, Tucson, Arizona, United States
🇺🇸Compassionate Cancer Care Medical Group, Inc., Corona, California, United States
Gene Transfer for Cancer Pain
Phase 1
Completed
- Conditions
- Cancer Pain
- First Posted Date
- 2008-12-08
- Last Posted Date
- 2014-02-19
- Lead Sponsor
- Diamyd Inc
- Target Recruit Count
- 10
- Registration Number
- NCT00804076
- Locations
- 🇺🇸
Advanced Pharma CR, Miami, Florida, United States
🇺🇸Louisiana Research Associates, New Orleans, Louisiana, United States
🇺🇸University of Michigan Medical Center, Ann Arbor, Michigan, United States
News
No news found